These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Can 24-hour urine stone risk profiles predict urinary stone composition? Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026 [TBL] [Abstract][Full Text] [Related]
26. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis]. Leskovar P Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987 [TBL] [Abstract][Full Text] [Related]
27. [Stress and risk of urolith formation. I. The influence of stress on lithogenous urinary substances (author's transl)]. Brundig P; Berg W; Schneider HJ Urol Int; 1981; 36(3):199-207. PubMed ID: 7281375 [TBL] [Abstract][Full Text] [Related]
28. Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers. Sidhu H; Vaidyanathan S; Wangoo D; Rattan V; Thind SK; Nath R; Malakondaiah GC; Tandon SP Indian J Med Res; 1987 Oct; 86():500-5. PubMed ID: 3443483 [No Abstract] [Full Text] [Related]
29. Biochemical and dietary factors of uric acid stone formation. Trinchieri A; Montanari E Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885 [TBL] [Abstract][Full Text] [Related]
30. [Nephrolithiasis in patients with intestinal diseases]. Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917 [TBL] [Abstract][Full Text] [Related]
31. Update on the medical management of stone disease. Tracy CR; Pearle MS Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774 [TBL] [Abstract][Full Text] [Related]
32. Hyperuricosuria and calcium nephrolithiasis. Coe FL; Parks JH Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958 [No Abstract] [Full Text] [Related]
33. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors. Kleinman JG Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787 [TBL] [Abstract][Full Text] [Related]
34. Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals. Yang B; Dissayabutra T; Ungjaroenwathana W; Tosukhowong P; Srisa-Art M; Supaprom T; Insin N; Boonla C Ann Clin Lab Sci; 2014; 44(3):262-71. PubMed ID: 25117095 [TBL] [Abstract][Full Text] [Related]
35. Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis. Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z J Endourol; 2014 Jul; 28(7):871-6. PubMed ID: 24571654 [TBL] [Abstract][Full Text] [Related]
36. [EXPERIENCE OF USE OF BLEMAREN® IN THE TREATMENT OF PATIENTS IN URIC ACID AND CALCIUM OXALATE UROLITHIASIS]. Konstantinova OV; Yanenko EK Urologiia; 2015; (5):22-4, 26. PubMed ID: 26859932 [TBL] [Abstract][Full Text] [Related]
38. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes. Bell DS Diabetes Obes Metab; 2012 Apr; 14(4):299-303. PubMed ID: 21992452 [TBL] [Abstract][Full Text] [Related]
39. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812 [TBL] [Abstract][Full Text] [Related]